Finance

Lists
VVY:AMS
Vivoryon Therapeutics NV
€0.91
-0.65%
(-0.0060) 1D
Oct 20, 5:35:24 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VVY...
Open
€0.89
High
€0.92
Low
€0.89
Mkt. cap
25.28M
Avg. vol.
25.56K
Volume
47.20K
52-wk high
€1.68
52-wk low
€0.89
EPS
-€0.22
Shares outstanding
26.07M
No. of employees
13
Open
€0.89
High
€0.92
Low
€0.89
Mkt. cap
25.28M
Avg. vol.
25.56K
Volume
47.20K
52-wk high
€1.68
52-wk low
€0.89
EPS
-€0.22
Shares outstanding
26.07M
No. of employees
13
News stories
From web sources and news partners
About Vivoryon Therapeutics NV
CEO-
Employees13
Founded1997
Headquarters-
SectorBiotechnology
Websitevivoryon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
806.50K
806.50K
829.50K
829.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.02M
866.00K
866.00K
Operating expense
1.69M
1.69M
1.70M
1.70M
Total operating expenses
1.69M
1.69M
1.70M
1.70M
Operating income
-1.69M
-1.69M
-1.70M
-1.70M
Other non operating income
-
-
-
-
EBT including unusual items
-1.69M
-1.69M
-1.69M
-1.69M
EBT excluding unusual items
-1.69M
-1.69M
-1.69M
-1.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-132.50K
-132.50K
-
-
Net income
-1.69M
-1.69M
-1.69M
-1.69M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
15.50K
15.50K
13.50K
13.50K
Interest expense
-11.00K
-11.00K
-11.00K
-11.00K
Net interest expenses
4.50K
4.50K
2.50K
2.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.67M
-1.67M
-1.68M
-1.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps